Pediatric Neurology Briefs
Published 1995 | Version v1.0.0
Journal Article Open

5-Hydroxytryptophan in Friedreichs Ataxia

Creators

Abstract

The effect of the levorotatory form of 5-hydroxytryptophan (approx 1 gm/day/orally) on cerebellar symptoms in 26 patients with Friedreichs ataxia was evaluated in a double-blind drug-placebo study by the Ataxia Research Center, Hopital Neurologique, Lyon and 11 other research hospitals in France.

Files

PNB-9-44-b.pdf

Files (2.4 MB)

Name Size Download all
md5:f60cd331a7a79f0c2e5e215ee4324b04
2.4 MB Preview Download

Additional details

Identifiers

Other
PNB-9-44-b

Dates

Created
1995
When the item was originally created.